September #94 : Count Down - by Greg Lugliani

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Standing in the Shadows of Love

The Great Doctor / Patient Face-Off

Mailbox

Boy Talk

Girl Talk

Name Recognition

Dynamic Duos

Work That Visit!

It Takes a Villager

Urinetown

Devil in a Blue Dress

U.S. Armed Cervixes

Cell Culture

Milestones

Class Act

Good Book

Rape OutRAGE

It Happened in September

Hitting the Switch

Missed Doses

Overexposed

Count Down

Tailgating HIV

20%

Potty Mouth

Booty Call

London Calling

Test Drive

Aid for Medicaid

Editor's Letter

Lei'd in the Shade

The Wings Beneath His Wind



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

September 2003

Count Down

by Greg Lugliani

New classes of antiretrovirals aren’t gushing out of the pipeline today, but you can spot plenty of old stand-bys in new get-ups. The latest makeover: Agouron’s buff, 625-mg update of its protease inhibitor, nelfinavir (Viracept). FDA-approved in April, it slashes the 250-mg version’s pill count—from 10 to four—with the same twice-daily dosing.

Fewer pills can mean better adherence, and that’s grand. But some pipeline insiders worry that the new version may cause even more diarrhea than its bowel-loosening predecessor because of its greater bioavailability (how much of, and how fast, your body can process a substance). Richard Ogden, Agouron’s senior director of scientific development, told POZ their research shows “no increase in the frequency of diarrhea” at higher doses.

The new model joins the old on shelves this fall, and Ogden says many patients will be advised to switch. Only HIVers who do so will be able to tell if the new pill is the charm—or the Charmin.




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    charliehunter
    San Francisco
    California


    RyGuy00
    New York
    New York


    Deelight4u
    BROOKLYN
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.